Back to Search Start Over

A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15.

Authors :
Patsalos A
Halasz L
Medina-Serpas MA
Berger WK
Daniel B
Tzerpos P
Kiss M
Nagy G
Fischer C
Simandi Z
Varga T
Nagy L
Source :
The Journal of experimental medicine [J Exp Med] 2022 Jan 03; Vol. 219 (1). Date of Electronic Publication: 2021 Nov 30.
Publication Year :
2022

Abstract

Muscle regeneration is the result of the concerted action of multiple cell types driven by the temporarily controlled phenotype switches of infiltrating monocyte-derived macrophages. Pro-inflammatory macrophages transition into a phenotype that drives tissue repair through the production of effectors such as growth factors. This orchestrated sequence of regenerative inflammatory events, which we termed regeneration-promoting program (RPP), is essential for proper repair. However, it is not well understood how specialized repair-macrophage identity develops in the RPP at the transcriptional level and how induced macrophage-derived factors coordinate tissue repair. Gene expression kinetics-based clustering of blood circulating Ly6Chigh, infiltrating inflammatory Ly6Chigh, and reparative Ly6Clow macrophages, isolated from injured muscle, identified the TGF-β superfamily member, GDF-15, as a component of the RPP. Myeloid GDF-15 is required for proper muscle regeneration following acute sterile injury, as revealed by gain- and loss-of-function studies. Mechanistically, GDF-15 acts both on proliferating myoblasts and on muscle-infiltrating myeloid cells. Epigenomic analyses of upstream regulators of Gdf15 expression identified that it is under the control of nuclear receptors RXR/PPARγ. Finally, immune single-cell RNA-seq profiling revealed that Gdf15 is coexpressed with other known muscle regeneration-associated growth factors, and their expression is limited to a unique subpopulation of repair-type macrophages (growth factor-expressing macrophages [GFEMs]).<br />Competing Interests: Disclosures: The authors declare no competing interests exist.<br /> (© 2021 Patsalos et al.)

Details

Language :
English
ISSN :
1540-9538
Volume :
219
Issue :
1
Database :
MEDLINE
Journal :
The Journal of experimental medicine
Publication Type :
Academic Journal
Accession number :
34846534
Full Text :
https://doi.org/10.1084/jem.20210420